Company
Appili Therapeutics Inc
CVE:APLI
Appili Therapeutics was founded to advance the global fight against infectious disease by matching clearly defined patient needs with drug development programs that provide solutions to existing challenges patients, doctors, and society face in this challenging disease space. Appili has built a pipeline of assets designed to address a broad range of significant unmet medical needs in the infectious disease landscape.
2 stories
Appili Therapeutics starts trading on the TSX Venture Exchange
The company is focused on the acquisition and development of novel treatments targeting unmet needs in infectious disease